Received Mar 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y014306 | IM / RL |
Patient received MMRV instead of MMR. No adverse reaction observed after vaccine administration. No treatment, patient to be monitored for febrile seizure.
No
None
None
No
Not applicable